Detecting Potentially Harmful Mycotoxins in Beer

Article

Beer is one of the world's most popular alcoholic beverages. But, made with barley, brews can contain low levels of mycotoxins, which are produced by fungi that can contaminate grains. Although not a major health threat, the industry needs to minimize the risk of contamination. Now scientists have developed a portable sensor that can help. Their report appears in ACS' Journal of Agricultural and Food Chemistry.

Because of its alcohol content and the high temperatures required to make beer, most consumers might assume that contamination by biologically derived compounds is not an issue. But mycotoxins can survive the brewing process and end up in the final product. Some mycotoxins have been shown to cause genetic damage in cells and cancer in animals. Currently, methods to detect mycotoxin contamination in beer are costly and require in-laboratory analysis. Sweccha Joshi, Teris van Beek and colleagues wanted to come up with a less expensive, portable alternative.

Building on technology used to detect mycotoxins in grains, the researchers developed a biosensing chip that can bind these compounds when they are present in beer samples. The team also could reuse the chip 450 times before it started to fail. Testing on commercial beer and barley showed that the portable instrument detected levels as low as 0.2 nanograms/milliliter of ochratoxin A and 120 ng/mL of deoxynivalenol -- respectively, the estimated safe limits for these mycotoxins.

The authors acknowledge funding from the Netherlands Organisation for Scientific Research.

Source: American Chemical Society

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.
 Futuristic UV Sanitizer with Sleek Design on a white background.  (Adobe Stock 1375983522 by Napa)